Sage Journals: Discover world-class research

Abstract

Despite inattention being one of the most common symptoms of Post-COVID-19 Syndrome (PCS), there is a gap in the literature regarding its treatment. This report presents a case of attentional symptoms and fatigue that emerged after the SARS-CoV-2 infection. The symptoms were similar to ADHD in adults, although the 61-year-old patient had never experienced inattention symptoms before. The patient was initially treated with Methylphenidate and then Lisdexamfetamine. Both were adapted to the needs and treatment response presented by the patient. After several changes in the therapeutic regimen, including the addition of Bupropion, the patient achieved remission of his symptoms. This case highlights the importance of treating PCS inattention and fatigue as an ADHD-like syndrome, despite the evident different etiology of symptoms. It would be necessary to replicate these findings to confirm our results, thus benefiting other patients currently affected by this syndrome.

Keywords

Post-COVID-19 Syndrome ADHD Long Covid Brain Fog case report treatment

Get full access to this article

View all access options for this article.

References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-V (5th). Author.

Anbarasan

Kitchin

Adler

L. A.

(2020). Screening for adult ADHD. Current Psychiatry Reports, 22, 72. https://doi.org/10.1007/s11920-020-01194-9

Becker

J. H.

Lin

J. J.

Doernberg

Stone

Navis

Festa

J. R.

Wisnivesky

J. P.

(2021). Assessment of cognitive function in patients after COVID-19 infection. JAMA network open, 4(10), e2130645. https://doi.org/10.1001/jamanetworkopen.2021.30645

Belloni

Arrigoni

de Sanctis

Arcidiacono

M. A.

Dellafiore

Caruso

(2021). A systematic review of systematic reviews and pooled meta-analysis on pharmacological interventions to improve cancer-related fatigue. Critical Reviews in Oncology/Hematology, 166, 103373. https://doi.org/10.1016/j.critrevonc.2021.103373

Brevik

E. J.

Lundervold

A. J.

Haavik

Posserud

M. B.

(2020). Validity and accuracy of the adult attention-deficit/hyperactivity disorder (ADHD) self-report scale (ASRS) and the Wender Utah Rating Scale (WURS) symptom checklists in discriminating between adults with and without ADHD. Brain and Behavior, 10(6), e01605. https://doi.org/10.1002/brb3.1605

Ceban

Ling

Lui

L. M. W.

Lee

Gill

Teopiz

K. M.

Rodrigues

N. B.

Subramaniapillai

Di Vincenzo

J. D.

Cao

Lin

Mansur

R. B.

R. C.

Rosenblat

J. D.

Miskowiak

K. W.

Vinberg

Maletic

McIntyre

R. S.

(2022). Fatigue and cognitive impairment in Post-COVID-19 syndrome: A systematic review and meta-analysis. Brain, Behavior, and Immunity, 101, 93–135. https://doi.org/10.1016/j.bbi.2021.12.020

Crunfli

Carregari

V. C.

Veras

F. P.

Silva

L. S.

Nogueira

M. H.

Antunes

A. S. L. M.

Vendramini

P. H.

Valença

A. G. F.

Brandão-Teles

Zuccoli

G. D. S.

Reis-de-Oliveira

Silva-Costa

L. C.

Saia-Cereda

V. M.

Smith

B. J.

Codo

A. C.

de Souza

G. F.

Muraro

S. P.

Parise

P. L.

Toledo-Teixeira

D. A.

. . . Martins-de-Souza

(2022). Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proceedings of the National Academy of Sciences of the United States of America, 119(35), e2200960119. https://doi.org/10.1073/pnas.2200960119

Hoogman

Bralten

Hibar

D. P.

Mennes

Zwiers

M. P.

Schweren

van Hulzen

Medland

S. E.

Shumskaya

Jahanshad

Zeeuw

Szekely

Sudre

Wolfers

Onnink

Dammers

J. T.

Mostert

J. C.

Vives-Gilabert

Kohls

Franke

(2017). Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: A cross-sectional mega-analysis. The Lancet Psychiatry, 4(4), 310–319. https://doi.org/10.1016/S2215-0366(17)30049-4

Hoogman

Muetzel

Guimaraes

J. P.

Shumskaya

Mennes

Zwiers

M. P.

Jahanshad

Sudre

Wolfers

Earl

E. A.

Soliva Vila

J. C.

Vives-Gilabert

Khadka

Novotny

S. E.

Hartman

C. A.

Heslenfeld

D. J.

Schweren

Ambrosino

Oranje

. . . Franke

(2019). Brain imaging of the cortex in ADHD: A coordinated analysis of large-scale clinical and population-based samples. American Journal of Psychiatry, 176(7), 531–542. https://doi.org/10.1176/appi.ajp.2019.18091033

10.

Jain

Montano

C. B.

(2017). Addressing diagnosis and treatment gaps in adults with attention-deficit/Hyperactivity disorder. The Primary Care Companion For CNS Disorders, 19(5), 17nr02153. https://doi.org/10.4088/PCC.17nr02153

11.

Kao

Frankland

P. W.

(2022). COVID fog demystified. Cell, 185(14), 2391–2393. https://doi.org/10.1016/j.cell.2022.06.020

12.

Kessler

R. C.

Adler

Ames

Demler

Faraone

Hiripi

Howes

M. J.

Jin

Secnik

Spencer

Ustun

T. B.

Walters

E. E.

(2005). The World Health Organization adult ADHD self-report scale (ASRS): A short screening scale for use in the general population. Psychological Medicine, 35(2), 245–256. https://doi.org/10.1017/s0033291704002892

13.

Kooij

S. J.

Bejerot

Blackwell

Caci

Casas-Brugué

Carpentier

P. J.

Edvinsson

Fayyad

Foeken

Fitzgerald

Gaillac

Ginsberg

Henry

Krause

Lensing

M. B.

Manor

Niederhofer

Nunes-Filipe

Ohlmeier

M. D.

. . . Asherson

(2010). European consensus statement on diagnosis and treatment of adult ADHD: The European network adult ADHD. BMC Psychiatry, 10(1), 67. https://doi.org/10.1186/1471-244X-10-67

14.

Lopez-Leon

Wegman-Ostrosky

Perelman

Sepulveda

Rebolledo

P. A.

Cuapio

Villapol

(2021). More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. medRxiv : the preprint server for health sciences. 01.27.21250617. https://doi.org/10.1101/2021.01.27.21250617

15.

Manu

(2022). Repurposing drugs for Post-COVID-19 Fatigue Syndrome: methylphenidate, duloxetine, and brexpiprazole. American Journal of Therapeutics, 29(2), e229–e230. https://doi.org/10.1097/MJT.0000000000001471

16.

Mattos

Segenreich

Saboya

Louzã

Dias

Romano

(2006). Adaptação transcultural para o português da escala adult self-report scale para avaliação do transtorno de déficit de atenção/hiperatividade (TDAH) em adultos. Archives of Clinical Psychiatry, 33(4), 188–194. https://doi.org/10.1590/s0101-60832006000400004

17.

Mirza

S. A.

Sheikh

A. A. E.

Barbera

Ijaz

Javaid

M. A.

Shekhar

Pal

Sheikh

A. B.

(2022). COVID-19 and the endocrine system: A review of the current information and misinformation. Infectious Disease Reports, 14(2), 184–197. https://doi.org/10.3390/idr14020023

18.

Pievsky

M. A.

McGrath

R. E.

(2018). Neurocognitive effects of methylphenidate in adults with attention-deficit/hyperactivity disorder: A meta-analysis. Neuroscience and Biobehavioral Reviews, 90, 447–455. https://doi.org/10.1016/j.neubiorev.2018.05.012

19.

Raveendran

A. V.

Jayadevan

Sashidharan

(2021). Long COVID: An overview. Diabetes & Metabolic Syndrome, 15(3), 869–875. https://doi.org/10.1016/j.dsx.2021.04.007

20.

Riley

D. S.

Barber

M. S.

Kienle

G. S.

Aronson

J. K.

von Schoen-Angerer

Tugwell

Kiene

Helfand

Altman

D. G.

Sox

Werthmann

P. G.

Moher

Rison

R. A.

Shamseer

Koch

C. A.

Sun

G. H.

Hanaway

Sudak

N. L.

Kaszkin-Bettag

. . . Gagnier

J. J.

(2017). CARE guidelines for case reports: Explanation and elaboration document. Journal of Clinical Epidemiology, 89, 218–235. https://doi.org/10.1016/j.jclinepi.2017.04.026

21.

Sartori

A. C.

Vance

D. E.

Slater

L. Z.

Crowe

(2012). The impact of inflammation on cognitive function in older adults: Implications for healthcare practice and research. Journal of Neuroscience Nursing, 44(4), 206–217. https://doi.org/10.1097/JNN.0b013e3182527690

22.

Schou

T. M.

Joca

Wegener

Bay-Richter

(2021). Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review. Brain, Behavior, and Immunity, 97, 328–348. https://doi.org/10.1016/j.bbi.2021.07.018

23.

Taquet

Sillett

Zhu

Mendel

Camplisson

Dercon

Harrison

P. J.

(2022). Neurological and psychiatric risk trajectories after SARS-Cov-2 infection: An analysis of 2-year retrospective cohort studies including 1 284 437 patients. The Lancet Psychiatry, 9(10), 815–827. https://doi.org/10.1016/s2215-0366(22)00260-7

24.

Tenforde

M. W.

Kim

S. S.

Lindsell

C. J.

Billig Rose

Shapiro

N. I.

Files

D. C.

Gibbs

K. W.

Erickson

H. L.

Steingrub

J. S.

Smithline

H. A.

Gong

M. N.

Aboodi

M. S.

Exline

M. C.

Henning

D. J.

Wilson

J. G.

Khan

Qadir

Brown

S. M.

Peltan

I. D.

. . . Wu

M. J.

; IVY Network Investigators. (2020). Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. MMWR Morbidity and Mortality Weekly Report, 69(30), 993–998. https://doi.org/10.15585/mmwr.mm6930e1

25.

Theoharides

T. C.

Cholevas

Polyzoidis

Politis

(2021). Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. Biofactors, 47(2), 232–241. https://doi.org/10.1002/biof.1726

26.

Warren

Drake

C. K.

(2022). Cognitive complications of COVID-19 infection. Rhode Island Medical Journal, 105(7), 27–30.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB

Successful Treatment of Post-COVID-19 ADHD-like Syndrome: A Case Report

Abstract

Keywords

Get full access to this article

References

Supplementary Material